Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Reducing residual cardiovascular risk with novel therapies.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reducing residual cardiovascular risk with novel therapies.
Reducing residual cardiovascular risk with novel therapies. Curr Opin Lipidol. 2020 04; 31(2):108-110.
View in:
PubMed
subject areas
Anticholesteremic Agents
Cardiovascular Diseases
Humans
Hypolipidemic Agents
authors with profiles
Michael H. Davidson